Cite
APA Citation
Valentin, J., Atienzar, F., Class, R., Delaunois, A., Fleurance, R., Gerets, H., Glineur, S., Gryshkova, V., Hall, P., Hasselgren, C., & Tilmant, K. (n.d.). de-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development. Toxicology letters, 280, S77–. http://access.bl.uk/ark:/81055/vdc_100053366669.0x000033